| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6063861 | Journal of Allergy and Clinical Immunology | 2013 | 19 Pages |
Abstract
Inhibiting TNF-α or src kinases may be a therapeutic option to normalize barrier integrity and cytokine release in airway diseases associated with barrier dysfunction.
Keywords
proMMP-9ECLMSDSFKTSLPMDCKHRPHBECFITCSrc kinasemAbThymic stromal lymphoproteinSU6656MMPSrc family kinaseMonoclonal antibodyTight junctionElectrochemiluminescenceAliEpithelialBronchialTERAirwayTIMPHuman bronchial epithelial cellCytokinesTNF-αfluorescein isothiocyanatelactate dehydrogenaseLDHMatrix metalloproteaseBarriertransepithelial electrical resistanceTissue inhibitor of metalloproteinaseair-liquid InterfaceHorseradish peroxidaseadherens junctionsMeso Scale Discovery
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michelle A. PhD, Emily BSc, Emma BMedSci, Nivenka P. MD, Cornelia PhD, Emily J. PhD, Neil PhD, Stephen T. MD, DSc, Peter H. MD, DM, Donna E. PhD, Jane E. PhD,